See more : Sogou Inc. (SOGO) Income Statement Analysis – Financial Results
Complete financial analysis of Medical Supply International USA, Inc. (MSIU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Supply International USA, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Anfu CE LINK Limited (300787.SZ) Income Statement Analysis – Financial Results
- Shibaura Electronics Co.,Ltd. (6957.T) Income Statement Analysis – Financial Results
- Woori Financial Group Inc. (WF) Income Statement Analysis – Financial Results
- SE Holdings and Incubations Co., Ltd. (9478.T) Income Statement Analysis – Financial Results
- Vuno Inc. (338220.KQ) Income Statement Analysis – Financial Results
Medical Supply International USA, Inc. (MSIU)
Industry: Medical - Devices
Sector: Healthcare
About Medical Supply International USA, Inc.
Medical Supply International USA, Inc., together with its subsidiaries, provides rehabilitation services and specialized hospital services in the healthcare industry in the People's Republic of China. It operates rehabilitative center, and maternity and specialized service hospital. The rehabilitative center serves patients who have survived from a serious injury or illness or an addiction and are seeking therapeutic or medical treatment. The company also operates outpatient clinic and offers other services, including private outpatients and health check-up services, and obstetrics and gynecology services. It offers 4-D ultrasound system applications for scanning for medical purposes, IPL system applications for treatment various kinds of skin disorder, and cosmetic surgery. The company was formerly known as Master Spirit International USA Inc. and changed its name to Medical Supply International USA, Inc. in October 2018. Medical Supply International USA, Inc. was founded in 2001 and is headquartered in Wan Chai, Hong Kong.
Metric | 2017 | 2016 | 2005 |
---|---|---|---|
Revenue | 2.82M | 3.64M | 362.07K |
Cost of Revenue | 1.06M | 1.98M | 557.88K |
Gross Profit | 1.76M | 1.66M | -195.81K |
Gross Profit Ratio | 62.42% | 45.69% | -54.08% |
Research & Development | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 |
SG&A | 1.32M | 1.65M | 445.57K |
Other Expenses | 0.00 | 0.00 | 0.00 |
Operating Expenses | 1.32M | 1.65M | 445.57K |
Cost & Expenses | 2.38M | 3.63M | 1.00M |
Interest Income | 0.00 | 0.00 | 0.00 |
Interest Expense | 43.34K | 4.73K | 56.65K |
Depreciation & Amortization | 17.88K | 21.89K | 184.96K |
EBITDA | 456.06K | 32.30K | -385.73K |
EBITDA Ratio | 16.19% | 0.89% | -126.06% |
Operating Income | 438.18K | 10.39K | -641.37K |
Operating Income Ratio | 15.55% | 0.29% | -177.14% |
Total Other Income/Expenses | -43.34K | -4.73K | 14.04K |
Income Before Tax | 394.84K | 5.67K | -627.33K |
Income Before Tax Ratio | 14.01% | 0.16% | -173.26% |
Income Tax Expense | 2.00 | -3.00 | 4.00 |
Net Income | 394.84K | 5.67K | -627.33K |
Net Income Ratio | 14.01% | 0.16% | -173.26% |
EPS | 0.02 | 0.00 | -0.03 |
EPS Diluted | 0.02 | 0.00 | -0.03 |
Weighted Avg Shares Out | 25.51M | 25.51M | 18.33M |
Weighted Avg Shares Out (Dil) | 25.51M | 25.51M | 18.33M |
Source: https://incomestatements.info
Category: Stock Reports